This Solicitation opportunity from Department Of Defense was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
DIBUCAINE OINTMENT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Dibucaine Ointment, USP, is a rectally administered topical medication containing 1 percent dibucaine as the active ingredient, supplied in collapsible tubes with a rectal applicator for external use only. Each unit of issue is a 1-ounce (28-gram) package, with a total shelf life of 36 months requiring a minimum of 31 months of remaining shelf life upon receipt by the first government activity. Storage must be maintained between 15–30°C (59–86°F). Labeling must include the National Stock Number, manufacturer name, date of manufacture, expiration or retest date, contract number, and lot number, in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items. Packaging must be commercial and sealed to prevent damage, with exterior shipping containers ensuring safe delivery at the lowest cost via common carrier. Non-hazardous items must comply with ASTM D3951, but DLA Master List requirements take precedence. Hazardous materials must meet TQ requirement IP025 per FED-STD-313. Palletization must follow RP001, DLA Packaging Requirements for Procurement. This item is regulated by the FDA, and contractors must submit referral information through EBS. The National Stock Number is 6505-00-299-9535, with a purchase request number 7016779194 and a quantity of 5 units. Delivery is FOB destination within 20 days of order receipt, with the delivery address specified as FPO AP 96678. Inspection and acceptance occur at the destination, and invoicing must be submitted via Wide Area WorkFlow (WAWF). The contract is awarded under solicitation SPE2DP-26-T-3402, issued on May 14, 2026, with a response deadline of May 20, 2026. Applicable FAR and DFARS clauses govern socioeconomic representations, small business program compliance, trafficking in persons, employment eligibility, hazard communication, cybersecurity safeguards, transportation, and contract modifications. Offerors must provide a Unique Entity ID and CAGE code if involved in covered defense telecommunications, and must affirm size and socioeconomic status including WOSB, SDVOSB, HUBZone, and SDB classifications, though no offeror responses
General Info
Agency
Contract Value
$35NAICS
Place of Performance
UNIT 100494 BOX 1, FPO, AP, 96678, USASet-Aside
Awardee
Award Issued Date
Timeline
Submission Closed
Organization & Contact Information
Full Description
DIBUCAINE OINTMENT,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
CONTAINS 1 PERCENT OF DIBUCAINE OINTMENT
AS THE ACTIVE INGREDIENT
.
COMES SUPPLIED IN A COLLAPSIBLE TUBE
AND RECTAL APPLICATOR
.
RECTALLY ADMINISTERED
.
FOR EXTERNAL USE ONLY
.
UNIT OF ISSUE IS A PACKAGE CONTAINING
ONE (1) OUNCE OR 28 GRAMS
.
TOTAL SHELF LIFE IS 36 MONTHS.
.
THERE SHALL BE A MINIMUM OF 31 MONTHS
OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT
BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT 15-30 DEGREES CELSIUS OR
59 TO 86 DEGREES FARENHEIT
.
LABELING AND MARKING:
MUST INCLUDE THE FOLLOWING:
NATIONAL STOCK NUMBER,
MANUFACTURER,
DATE OF MANUFACTURER,
EXPIRATION DATE OR RETEST DATE,
CONTRACT NUMBER
AND LOT NUMBER
.
1/7/2015
1 PG = 28 GM
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
SPE2DP-26-T-3402
SECTION B
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00536-1211-95
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016779194 0001 PG 5.000
NSN/MATERIAL:6505002999535
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
SPE2DP-26-T-3402
SECTION B
PR: 7016779194 PRLI: 0001 CONT’D
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N23193
USNS ALAN SHEPARD T AKE 3
UNIT 100494 BOX 1
FPO AP 96678
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
N23193
USNS ALAN SHEPARD T AKE 3
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N231936133S283
RDD: 777
PROJ: HJ5 TP 2
SUPP ADD: YPHARM SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:05/18/2026
SPE2DP-26-T-3402 NSN/Part Number: 6505-00-299-9535 Quantity: 5 PG Purchase Request: 7016779194QTY: 5 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS